Press Releases

Flare Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate FX-909 in Combination with KEYTRUDA® (pembrolizumab) in New Cohort of Ongoing Phase 1 Trial in Metastatic Urothelial Cancer

CAMBRIDGE, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced...

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Biomarkers identified in BriaCell’s Phase 2 study are showing similar and encouraging trends in the ongoing pivotal Phase 3 study of Bria-IMT™ in metastatic breast cancer (MBC) No new safety or tolerability issues identified in pooled analysis of...

Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025

Management to host conference call on Thursday, October 30, 2025, at 8:00 am EDT FLORHAM PARK, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and...

Ricotta Market Worth USD 790.24 Million in 2024 - Trends & Growth Forecast

Ricotta, beyond its cultural heritage, emerges as a culinary marvel, effortlessly blending into an extensive repertoire of savory and sweet dishes. WILMINGTON, DE, UNITED STATES, October 21, 2025 /⁨EINPresswire.com⁩/ -- Ricotta Market valued at...

Exercise counteracts junk food's depression-like effects through gut-brain metabolic signaling

Researchers reveal how running mitigates cafeteria diet-induced behavioral changes in rats. The findings identify mechanisms linking lifestyle to mental health CORK, MUNSTER, IRELAND, October 21, 2025 /⁨EINPresswire.com⁩/ -- Researchers led by...

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO®...

Standard Lithium Prices Upsized $130 Million Underwritten Public Offering

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, announced the pricing of its previously announced...

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

– Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and consistent safety profile – STAMFORD, Conn.,...

Standard Lithium Announces Proposed Public Offering of Common Shares

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, announced that it intends to offer and sell common...

Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer

VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of...

Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for...

Wintrust Financial Corporation Reports Record Net Income

ROSEMONT, Ill., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced record net income of $600.8 million, or $8.25 per diluted common share, for the first nine months...

Bittam Leads the New Era of Contract Trading: Zero Slippage, Zero Funding Fees，Launches a 10% Loss Rebate Bonus

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- After Bitcoin surged past the $125,800 mark to set a new all-time high, the market quickly entered a phase of short-term correction. Many traders are now asking: is this a signal of a top, or simply a...

Artificial Lung Market to Grow at 10.84% CAGR, Hits USD 7.05 Bn by 2034

Ottawa, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The global artificial lung market size was valued at USD 2.51 billion in 2024 and is predicted to hit around USD 7.05 billion by 2034, rising at a 10.84% CAGR, a study published by Towards Healthcare a...

Security Printing Services Market Size, Segments, Share and Companies (2025-34)

Ottawa, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The global security printing services market size was recorded at USD 33.16 billion in 2025 and is forecast to increase to USD 48.43 billion in 2034, as per findings from a study published by Towards...

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “Company”), today announced that it has entered into a non-binding Strategic Partnership Term Sheet with BirchBioMed Inc. (“Birch”), a...

ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing...

Sandhoff Disease Treatment Market Size Projects USD 456.42 Million by 2034

Ottawa, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The global Sandhoff disease treatment market size was valued at USD 260 million in 2024 and is predicted to hit around USD 456.42 million by 2034, rising at a 5.75% CAGR, a study published by Towards...

Gradient MSP Launches MSP Studio+: Marketing Made Simple for MSPs

MSP Studio+ combines professionally designed and ready-to-use marketing content with rebranding automation and social publishing in a single solution for MSPs. CALGARY, ALBERTA, CANADA, October 15, 2025 /⁨EINPresswire.com⁩/ -- Gradient MSP today...

Wisp & Vesalius Forge Women-Centric Longevity Path With Peptide Therapy Launch

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vesalius Longevity Labs, the first soon-to-be publicly traded company dedicated exclusively to longevity science, today announced a landmark partnership with Wisp, the largest women’s telehealth provider...